TapewireFind a company

person · Reporting owner

DUNTON ALAN W

Disclosed activity across 3 companies

Tapewire entity
26392
SEC CIK
0001304773

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CorMedix Inc.CRMD · Entity 5280DirectorJanuary 26, 2026January 28, 2026
ORAGENICS INCOGEN · Entity 8495DirectorDecember 11, 2025December 15, 2025
PALATIN TECHNOLOGIES INCPTN · Entity 7649DirectorAugust 03, 2026August 05, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CorMedix Inc.

Report date January 26, 2026 · Filed January 28, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect70,703 Reported balance After 2026-01-26 transaction · row 1
1 source row

Row 1 · 2026-01-26 · Grant · Acquired 30,453 · Balance 70,703

F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.

ORAGENICS INC

Report date December 11, 2025 · Filed December 15, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Non-Employee Director Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.93 · Expires 2035-12-11Direct125,000 Reported balance After 2025-12-11 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-12-11 · Grant · Acquired 125,000 · Balance 125,000

F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

PALATIN TECHNOLOGIES INC

Report date August 03, 2026 · Filed August 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
StockOption (Right toBuy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.70 · Expires 2037-08-03Direct25,769 Reported balance After 2026-08-03 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-08-03 · Other · Acquired 2,200 · Balance 25,769

F1: Stock Option granted under the 2011 Stock Incentive Plan as amended. The option vests as to 50% on August 3, 2027 and as to the remaining 50% on August 3, 2028. The option was granted by the Compensation Committee on August 3, 2026, and there was no impediment to the grant of option.

Filing footnotes · ownership attribution and instrument terms

F1: Stock Option granted under the 2011 Stock Incentive Plan as amended. The option vests as to 50% on August 3, 2027 and as to the remaining 50% on August 3, 2028. The option was granted by the Compensation Committee on August 3, 2026, and there was no impediment to the grant of option.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 03, 2026 Filed Aug 5, 2026 20:30 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 OtherStockOption (Right toBuy) · Derivative 2,200 $0.00 Strike: $7.70 $0.00
Disclosure

SEC source: 0001493152-26-036186 · ownership.xml · derivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,769

Underlying: Common Stock · 2,200 shares

Expires 2037-08-03

F1 · derivative.exercise_date: Stock Option granted under the 2011 Stock Incentive Plan as amended. The option vests as to 50% on August 3, 2027 and as to the remaining 50% on August 3, 2028. The option was granted by the Compensation Committee on August 3, 2026, and there was no impediment to the grant of option.

Read SEC document
January 26, 2026 Filed Jan 28, 2026 02:30 UTC CorMedix Inc. CRMD · Entity 5280 GrantCommon Stock 30,453 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-008475 · ownership.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,703

F1 · price: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.

Read SEC document
December 30, 2025 Filed Jan 3, 2026 02:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 20,000 $0.00 Strike: $4.03 $0.00
Disclosure

SEC source: 0001213900-26-000712 · ownership.xml · derivative · entry 3

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on 2/22/2022. These options are fully vested.

Read SEC document
December 30, 2025 Filed Jan 3, 2026 02:30 UTC CorMedix Inc. CRMD · Entity 5280 SaleCommon Stock 20,000 $13.00 $260,000.00
Disclosure

SEC source: 0001213900-26-000712 · ownership.xml · nonDerivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,250

Read SEC document
December 30, 2025 Filed Jan 3, 2026 02:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionCommon Stock 20,000 $4.03 $80,600.00
Disclosure

SEC source: 0001213900-26-000712 · ownership.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 11, 2025 Filed Dec 15, 2025 21:25 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0001304773-25-000003 · primary_doc.xml · derivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-12-11

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
December 09, 2025 Filed Dec 11, 2025 22:00 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantStock Option (Right to Buy) · Derivative 1,200 $0.00 Strike: $21.38 $0.00
Disclosure

SEC source: 0001493152-25-027267 · ownership.xml · derivative · entry 4

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,999

Underlying: Common Stock · 1,200 shares

Expires 2026-12-09

F4 · derivative.exercise_date: Stock Options granted under the 2011 Stock Incentive Plan, the option vests as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options.

F4 · derivative.expiration_date: Stock Options granted under the 2011 Stock Incentive Plan, the option vests as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options.

Read SEC document
December 09, 2025 Filed Dec 11, 2025 22:00 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantStock Option (Right to Buy) · Derivative 1,200 $0.00 Strike: $21.38 $0.00
Disclosure

SEC source: 0001493152-25-027267 · ownership.xml · derivative · entry 3

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,799

Underlying: Common Stock · 1,200 shares

Expires 2035-12-09

F3 · derivative.exercise_date: Stock Options granted under the 2011 Stock Incentive Plan, the option vests on December 9,2026, and in the event that the director does not serve until December 31, 2026, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on January 31, 2026. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the options.

F3 · derivative.expiration_date: Stock Options granted under the 2011 Stock Incentive Plan, the option vests on December 9,2026, and in the event that the director does not serve until December 31, 2026, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on January 31, 2026. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the options.

Read SEC document
December 09, 2025 Filed Dec 11, 2025 22:00 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-027267 · ownership.xml · nonDerivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,081

F2 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The restricted share units were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the restricted stock units.

F2 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The restricted share units were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the restricted stock units.

Read SEC document
December 09, 2025 Filed Dec 11, 2025 22:00 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-027267 · ownership.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,081

F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on December 9, 2026. The restricted share units were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the restricted stock units.

F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on December 9, 2026. The restricted share units were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the restricted stock units.

Read SEC document
September 12, 2025 Filed Sep 17, 2025 01:45 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 10,000 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0001213900-25-088337 · ownership.xml · derivative · entry 3

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 10,000 shares

Expires 2034-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Read SEC document
September 12, 2025 Filed Sep 17, 2025 01:45 UTC CorMedix Inc. CRMD · Entity 5280 SaleCommon Stock 10,000 $13.13 $131,300.00
Disclosure

SEC source: 0001213900-25-088337 · ownership.xml · nonDerivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,250

F1 · price: This transaction was executed in multiple trades at prices ranging from $13.00 to $13.25. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
September 12, 2025 Filed Sep 17, 2025 01:45 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionCommon Stock 10,000 $3.55 $35,500.00
Disclosure

SEC source: 0001213900-25-088337 · ownership.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:35 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 PurchaseSeries I warrants · Derivative 363,636 $0.00 Strike: $0.11 $0.00
Disclosure

SEC source: 0001654954-25-007105 · section16.xml · derivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 420,016

Underlying: Common Stock · 363,636 shares

Expires not disclosed

F1 · price: Each share of Series D Convertible Preferred Stock has a stated value of $100 per share, and is convertible to common stock at an initial conversion price of $0.11 per share, for a total of 181,818 shares of common stock. The Series D Preferred Stock and Series I common stock purchase warrants were sold at a combined offering price of $0.11 per share of common stock obtainable upon conversion of the Series D Convertible Preferred Stock.

F2 · derivative.exercise_date: The Series I warrants are exercisable on or after the date that approval is obtained from the Issuer's stockholders as may be required by the NYSE American (or any successor entity) (the "Stockholder Approval Date"), and will expire on the five-year anniversary of the Stockholder Approval Date, subject to the terms and conditions contained in such Series I warrant.

F2 · derivative.expiration_date: The Series I warrants are exercisable on or after the date that approval is obtained from the Issuer's stockholders as may be required by the NYSE American (or any successor entity) (the "Stockholder Approval Date"), and will expire on the five-year anniversary of the Stockholder Approval Date, subject to the terms and conditions contained in such Series I warrant.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:35 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 PurchaseSeries D Preferred Stock 200 $20,000.00 $4,000,000.00
Disclosure

SEC source: 0001654954-25-007105 · section16.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,112

F1 · shares: Each share of Series D Convertible Preferred Stock has a stated value of $100 per share, and is convertible to common stock at an initial conversion price of $0.11 per share, for a total of 181,818 shares of common stock. The Series D Preferred Stock and Series I common stock purchase warrants were sold at a combined offering price of $0.11 per share of common stock obtainable upon conversion of the Series D Convertible Preferred Stock.

Read SEC document
January 17, 2025 Filed Jan 23, 2025 02:10 UTC CorMedix Inc. CRMD · Entity 5280 GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-005674 · ownership.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,250

F1 · price: These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 23:07 UTC ORAGENICS INC OGEN · Entity 8495 SaleCommon Stock 66 $0.36 $23.76
Disclosure

SEC source: 0001493152-24-049325 · ownership.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,623

Read SEC document
September 19, 2024 Filed Sep 21, 2024 01:15 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 65,000 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-24-037728 · ownership.xml · derivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2034-09-19

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
July 15, 2024 Filed Jul 16, 2024 20:31 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantStock Option (Right to Buy) · Derivative 17,000 $0.00 Strike: $183.00 $0.00
Disclosure

SEC source: 0001654954-24-009001 · section16.xml · derivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,780

Underlying: Common Stock · 17,000 shares

Expires 2034-06-04

F2 · derivative.exercise_date: The option vests on June 4, 2025, and in the event that the director does not serve until June 30, 2025, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on July 31, 2024. The options were granted by the Compensation Committee on June 4, 2024, which grant was subject to certification by the Chief Financial Officer that the shareholders had increased the shares reserved under the 2011 Stock Incentive Plan, and that there were no impediments to the grant of the options. The required certification was made on July 15, 2024.

Read SEC document
July 15, 2024 Filed Jul 16, 2024 20:31 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0001654954-24-009001 · section16.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,294

F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 4, 2025. The restricted share units were granted by the Compensation Committee on June 4, 2024, which grant was subject to certification by the Chief Financial Officer that the shareholders had increased the shares reserved under the 2011 Stock Incentive Plan, and that there were no impediments to the grant of the options. The required certification was made on July 15, 2024.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 15:14 UTC Amendment PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantStock Option (Right to Buy) · Derivative 17,000 $0.00 Strike: $1.83 $0.00
Disclosure

SEC source: 0001654954-24-009045 · section16.xml · derivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,780

Underlying: Common Stock · 17,000 shares

Expires 2034-06-04

F2 · derivative.exercise_date: The option vests on June 4, 2025, and in the event that the director does not serve until June 30, 2025, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on July 31, 2024. The options were granted by the Compensation Committee on June 4, 2024, which grant was subject to certification by the Chief Financial Officer that the shareholders had increased the shares reserved under the 2011 Stock Incentive Plan, and that there were no impediments to the grant of the options. The required certification was made on July 15, 2024.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 15:14 UTC Amendment PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0001654954-24-009045 · section16.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,294

F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 4, 2025. The restricted share units were granted by the Compensation Committee on June 4, 2024, which grant was subject to certification by the Chief Financial Officer that the shareholders had increased the shares reserved under the 2011 Stock Incentive Plan, and that there were no impediments to the grant of the options. The required certification was made on July 15, 2024.

Read SEC document
March 05, 2024 Filed Mar 20, 2024 20:24 UTC CorMedix Inc. CRMD · Entity 5280 GrantStock Option (Right to Buy Common Stock) · Derivative 30,000 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0000899140-24-000322 · form4.xml · derivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-03-05

F1 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:47 UTC CorMedix Inc. CRMD · Entity 5280 PurchaseCommon Stock 3,000 $3.30 $9,900.00
Disclosure

SEC source: 0000929638-23-003434 · form4.xml · nonDerivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,250

Read SEC document
December 14, 2023 Filed Dec 18, 2023 21:47 UTC CorMedix Inc. CRMD · Entity 5280 PurchaseCommon Stock 3,000 $3.45 $10,350.00
Disclosure

SEC source: 0000929638-23-003434 · form4.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,250

Read SEC document
December 04, 2023 Filed Dec 6, 2023 22:02 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 SaleCommon Stock 1 $2.46 $2.46
Disclosure

SEC source: 0001654954-23-015219 · section16.xml · nonDerivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,074

Read SEC document
December 04, 2023 Filed Dec 6, 2023 22:02 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 SaleCommon Stock 199 $2.48 $493.52
Disclosure

SEC source: 0001654954-23-015219 · section16.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,075

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:30 UTC ORAGENICS INC OGEN · Entity 8495 GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-027577 · ownership.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,689

F1 · shares: Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months.

F2 · balance_after: Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023

Read SEC document
June 20, 2023 Filed Jun 22, 2023 21:00 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantStock Option (Right to Buy) · Derivative 16,000 $0.00 Strike: $2.19 $0.00
Disclosure

SEC source: 0001654954-23-008312 · section16.xml · derivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2033-06-20

F2 · derivative.exercise_date: The option vests on June 30, 2024, and in the event that the director does not serve until June 30, 2024, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on July 31, 2023.

Read SEC document
June 20, 2023 Filed Jun 22, 2023 21:00 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001654954-23-008312 · section16.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,807

F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 20, 2024.

F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 20, 2024.

Read SEC document
May 17, 2023 Filed May 17, 2023 23:08 UTC CorMedix Inc. CRMD · Entity 5280 GrantCommon Stock 3,000 $4.33 $12,979.80
Disclosure

SEC source: 0000929638-23-001520 · form4.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,250

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.31 to $4.34, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

Read SEC document
May 17, 2023 Filed May 18, 2023 21:05 UTC Amendment CorMedix Inc. CRMD · Entity 5280 PurchaseCommon Stock 3,000 $4.33 $12,979.80
Disclosure

SEC source: 0000929638-23-001531 · form4.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,250

F1 · kind: On May 17, 2023, the reporting person filed a Form 4 which inadvertently included Transaction Code "A". The original Form 4 should have indicated Transaction Code "P". The reporting person has filed this amendment to restate the transaction with the correct Transaction Code.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.31 to $4.34, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

Read SEC document
January 14, 2023 Filed Jan 18, 2023 23:59 UTC CorMedix Inc. CRMD · Entity 5280 GrantStock Option (Right to Buy Common Stock) · Derivative 20,000 $0.00 Strike: $4.43 $0.00
Disclosure

SEC source: 0001213900-23-003550 · ownership.xml · derivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-01-14

F1 · derivative.exercise_date: These options were granted on 1/14/2023. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Read SEC document
December 21, 2022 Filed Dec 23, 2022 22:30 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 SaleCommon Stock 200 $2.97 $594.00
Disclosure

SEC source: 0001654954-22-016941 · section16.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,420

Read SEC document
July 29, 2022 Filed Aug 2, 2022 20:32 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 220,000 $0.00 Strike: $0.36 $0.00
Disclosure

SEC source: 0001493152-22-021013 · ownership.xml · derivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,000

Underlying: Common Stock · 220,000 shares

Expires 2032-07-29

F1 · security: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022.

F1 · shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022.

F1 · derivative.underlying_shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022.

F1 · balance_after: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 23:31 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantStock Option (Right to Buy) · Derivative 128,000 $0.00 Strike: $0.29 $0.00
Disclosure

SEC source: 0001654954-22-008780 · section16.xml · derivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,000

Underlying: Common Stock · 128,000 shares

Expires 2032-06-22

F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2022.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 23:31 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantCommon Stock 73,000 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-008780 · section16.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 991,519

F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 22, 2023.

F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 22, 2023.

Read SEC document
February 22, 2022 Filed Feb 23, 2022 21:20 UTC CorMedix Inc. CRMD · Entity 5280 GrantStock Option (Right to Buy Common Stock) · Derivative 20,000 $0.00 Strike: $4.03 $0.00
Disclosure

SEC source: 0001213900-22-008959 · doc4.xml · derivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-02-22

F5 · derivative.exercise_date: These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Read SEC document
December 16, 2021 Filed Dec 17, 2021 22:04 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 75,000 $0.00 Strike: $0.49 $0.00
Disclosure

SEC source: 0001493152-21-031888 · ownership.xml · derivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2031-12-16

F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021.

F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021.

F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021.

F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021.

Read SEC document
June 30, 2021 Filed Jul 1, 2021 19:48 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantCommon Stock 10,000 $0.62 $6,200.00
Disclosure

SEC source: 0001654954-21-007518 · section16.xml · nonDerivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 786,518

Read SEC document
June 30, 2021 Filed Jul 1, 2021 19:48 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantCommon Stock 10,000 $0.62 $6,150.00
Disclosure

SEC source: 0001654954-21-007518 · section16.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 776,518

Read SEC document
June 30, 2021 Filed Jul 2, 2021 14:55 UTC Amendment PALATIN TECHNOLOGIES INC PTN · Entity 7649 PurchaseCommon Stock 10,000 $0.62 $6,200.00
Disclosure

SEC source: 0001654954-21-007562 · section16.xml · nonDerivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 786,518

F1 · kind: Amended to reflect open market purchases of non-derivative security.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 14:55 UTC Amendment PALATIN TECHNOLOGIES INC PTN · Entity 7649 PurchaseCommon Stock 10,000 $0.62 $6,150.00
Disclosure

SEC source: 0001654954-21-007562 · section16.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 776,518

F1 · kind: Amended to reflect open market purchases of non-derivative security.

Read SEC document
June 22, 2021 Filed Jun 24, 2021 21:01 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantStock Option (Right to Buy) · Derivative 128,000 $0.00 Strike: $0.55 $0.00
Disclosure

SEC source: 0001654954-21-007253 · section16.xml · derivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,000

Underlying: Common Stock · 128,000 shares

Expires 2031-06-22

F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2021.

Read SEC document
June 22, 2021 Filed Jun 24, 2021 21:01 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantCommon Stock 77,000 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-007253 · section16.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 766,518

F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 22, 2022.

F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 22, 2022.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 21:35 UTC ORAGENICS INC OGEN · Entity 8495 GrantNon-Employee Director Option (Right to Buy) · Derivative 160,000 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001493152-21-004422 · ownership.xml · derivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2031-02-18

F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021.

F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021.

F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021.

F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021.

Read SEC document
January 11, 2021 Filed Jan 14, 2021 02:32 UTC CorMedix Inc. CRMD · Entity 5280 GrantStock Option (Right to Buy Common Stock) · Derivative 30,000 $0.00 Strike: $8.32 $0.00
Disclosure

SEC source: 0001213900-21-002074 · doc4.xml · derivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-01-11

F1 · derivative.exercise_date: These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Read SEC document
August 12, 2020 Filed Aug 14, 2020 21:29 UTC CorMedix Inc. CRMD · Entity 5280 PurchaseCommon Stock 5,000 $3.95 $19,750.00
Disclosure

SEC source: 0001213900-20-022353 · doc4.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

Read SEC document
June 16, 2020 Filed Jun 18, 2020 21:02 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantStock option (right to buy) · Derivative 127,000 $0.00 Strike: $0.58 $0.00
Disclosure

SEC source: 0001654954-20-006793 · section16.xml · derivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,000

Underlying: Common Stock · 127,000 shares

Expires 2030-06-16

F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2020.

Read SEC document
June 16, 2020 Filed Jun 18, 2020 21:02 UTC PALATIN TECHNOLOGIES INC PTN · Entity 7649 GrantCommon Stock 73,000 $0.00 $0.00
Disclosure

SEC source: 0001654954-20-006793 · section16.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 578,935

F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021.

F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.